Bills › 90th General Assembly

HF 2668Signed by Governor · May 1, 2024

Relating to insurance coverage for biomarker testing

Sponsored by the House Appropriations (successor To Hf 2157) Committee

Topics:State budgetMedicaid

Same legislation: HF 2157, SF 2159, HF 2492

Where it is now

  1. Done: IntroducedJanuary 25, 2024
  2. Done: SubcommitteeJanuary 31, 2024
  3. Done: House committeeFebruary 8, 2024
  4. Done: Passes the HouseMarch 27, 202496–1
  5. Skipped: Senate committeeSkipped
  6. Done: Passes the SenateApril 9, 202446–0
  7. Done: To the GovernorApril 23, 2024
  8. Done: Signed into lawMay 1, 2024

Signed into law What’s a funnel?

What’s in it

This bill relates to health insurance coverage for biomarker testing. The bill defines “biomarker testing” as an analysis of an individual’s tissue, blood, or other biospecimen for the presence of a biomarker. “Biomarker” is also defined in the bill. The bill requires a health carrier that offers individual, group, or small group contracts, policies, or plans in this state that provide for third-party payment or prepayment of health or medical expenses to offer coverage for biomarker testing for purposes of diagnosing, treating, appropriately managing, or monitoring a disease or condition in a covered person when the test has demonstrated clinical utility as detailed in the bill.

Read the full explanation

“Clinical utility” is defined in the bill. Coverage shall be provided in a manner which limits disruptions in a person’s care. The bill requires a health carrier to provide a process on its internet site for a person and the person’s health care professional to seek an exception to coverage required under the bill. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2025, by the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the bill’s coverage requirements. The bill applies to the medical assistance program under Code chapter 249A, the healthy and well kids in Iowa (Hawki) program under Code chapter 514I, and a managed care organization acting pursuant to a contract with the department of health and human services to administer either the medical assistance program or the Hawki program. The commissioner of insurance may adopt rules to administer the bill. Under the bill, before November 1, 2025, the department of health and human services shall report the number of biomarker tests provided during fiscal year 2024–2025, and the resulting cost of providing the biomarker tests during fiscal year 2024–2025, to individuals pursuant to the bill that are covered by the medical assistance program under Code chapter 249A and the Hawki program under Code chapter 514I.

From the explanation printed with the bill as introduced, written by the Legislative Services Agency. Amendments adopted later aren’t reflected. Full bill text · What changed before it passed

Fiscal note

Cost: up to $171,000 Compare with other bills

House File 2668 is estimated to increase costs to the State by approximately $86,000 in FY 2025 and $171,000 annually beginning in FY 2026. Data to estimate potential cost savings is not currently available; therefore, potential cost savings as a result of the Bill are not included.

Nonpartisan cost estimates from the Legislative Services Agency’s Fiscal Services Division. The newest is first. Reading a fiscal note

Iowa Code it changes

Creates§514C.36

Read from the bill as introduced. Each links to every bill touching that chapter of the Iowa Code. How the Code works

Lobbying

19 for · 0 against · 28 undecided · Who →

Family tree

Where this legislation came from and where it went: earlier tries, the versions it moved through this Assembly, and later bills built on it.

Earlier and later bills are matched by wording or an identical title; check the text to be sure it’s the same idea.